Weitz Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-160,000
Closed -$7.4M 69
2015
Q2
$7.4M Hold
160,000
0.21% 58
2015
Q1
$6.86M Hold
160,000
0.19% 55
2014
Q4
$5.55M Hold
160,000
0.16% 58
2014
Q3
$5.18M Buy
160,000
+35,000
+28% +$1.17M 0.15% 58
2014
Q2
$4.24M Hold
125,000
0.13% 54
2014
Q1
$3.41M Sell
125,000
-25,000
-17% -$743K 0.11% 56
2013
Q4
$5.37M Hold
150,000
0.18% 53
2013
Q3
$4.52M Sell
150,000
-100,000
-40% -$3.27M 0.17% 52
2013
Q2
$7.29M Buy
+250,000
New +$7.05M 0.29% 47

Other funds holding PBH

Weitz Investment Management's PBH Position: Q3 2015 in Review

Weitz Investment Management sold out of Prestige Consumer Healthcare (PBH) in Q3 2015, closing a stake of 160,000 shares — an estimated $7.4M sold.

Weitz Investment Management first reported a position in PBH in Q2 2013 and held it in 9 quarters. The position peaked at $7.4M in Q2 2015. 206 funds tracked by Wall St. Rank hold PBH as of Q3 2015.

  • Weitz Investment Management reported no remaining Prestige Consumer Healthcare position as of Q3 2015 after selling out during the quarter.
  • Weitz Investment Management sold 160,000 Prestige Consumer Healthcare shares in Q3 2015, an estimated $7.4M.
  • Weitz Investment Management first reported a position in Prestige Consumer Healthcare in Q2 2013 and held it in 9 quarters.
  • Weitz Investment Management's Prestige Consumer Healthcare position peaked at $7.4M in Q2 2015.
  • 206 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2015.

Based on Weitz Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.